Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Goldberg

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Patient Preference and Adherence|October 18, 2023
Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best-Worst Scaling ResultsJohn F P Bridges, Joseph F Goldberg, Heather M Fitzgerald, et al.
The Journal of Clinical Psychiatry|August 7, 2008
Increased rate of non-right-handedness in patients with bipolar disorderCecylia Nowakowska, Gary S Sachs, Carlos A Zarate, et al.
The Journal of Clinical Psychiatry|September 28, 2010
Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the Systematic Treatment Enhancement Program for Bipolar DisorderJohn O Brooks, Joseph F Goldberg, Terence A Ketter, et al.
Biological Psychiatry|June 14, 2006
Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studiesJoseph R Calabrese, Joseph F Goldberg, Terence A Ketter, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 10, 2010
Transition to mania during treatment of bipolar depressionRoy H Perlis, Michael J Ostacher, Joseph F Goldberg, et al.
The Journal of Clinical Psychiatry|August 20, 2009
Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placeboJoseph F Goldberg, Joseph R Calabrese, Benjamin R Saville, et al.
Biological Psychiatry|June 5, 2007
Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorderJoseph F Goldberg, Charles L Bowden, Joseph R Calabrese, et al.
JAMA|February 22, 2022
Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical TrialSheldon H Preskorn, Scott Zeller, Leslie Citrome, et al.
The Journal of Clinical Psychiatry|October 27, 2007
Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)Christine J Truman, Joseph F Goldberg, S Nassir Ghaemi, et al.
Journal of Psychiatric Research|March 7, 2006
Overweight and obesity in bipolar disordersPo W Wang, Gary S Sachs, Carlos A Zarate, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Patient Preference and Adherence|October 18, 2023
Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best-Worst Scaling ResultsJohn F P Bridges, Joseph F Goldberg, Heather M Fitzgerald, et al.
The Journal of Clinical Psychiatry|August 7, 2008
Increased rate of non-right-handedness in patients with bipolar disorderCecylia Nowakowska, Gary S Sachs, Carlos A Zarate, et al.
The Journal of Clinical Psychiatry|September 28, 2010
Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the Systematic Treatment Enhancement Program for Bipolar DisorderJohn O Brooks, Joseph F Goldberg, Terence A Ketter, et al.
Biological Psychiatry|June 14, 2006
Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studiesJoseph R Calabrese, Joseph F Goldberg, Terence A Ketter, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 10, 2010
Transition to mania during treatment of bipolar depressionRoy H Perlis, Michael J Ostacher, Joseph F Goldberg, et al.
The Journal of Clinical Psychiatry|August 20, 2009
Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placeboJoseph F Goldberg, Joseph R Calabrese, Benjamin R Saville, et al.
Biological Psychiatry|June 5, 2007
Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorderJoseph F Goldberg, Charles L Bowden, Joseph R Calabrese, et al.
JAMA|February 22, 2022
Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical TrialSheldon H Preskorn, Scott Zeller, Leslie Citrome, et al.
The Journal of Clinical Psychiatry|October 27, 2007
Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)Christine J Truman, Joseph F Goldberg, S Nassir Ghaemi, et al.
Journal of Psychiatric Research|March 7, 2006
Overweight and obesity in bipolar disordersPo W Wang, Gary S Sachs, Carlos A Zarate, et al.
Pageof 18